Assyro AI

Orange Book product · Brand (NDA)

POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER

DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE

Brand (NDA)NDA 018362DISCN OTSUKA ICU MEDCL

At a glance

Mar 28, 1988

Approved

Brand (NDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Mar 28, 1988

    38 yr 9 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE

Strength

5GM/100ML;149MG/100ML;450MG/100ML

Dosage form

INJECTABLE

Route

INJECTION

TE code

Not listed

Application

NDA 018362

Product number

004

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.